Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 873 of 5804
-
Brain zapping without surgery: new device targets deep brain regions to treat depression and anxiety
Symptom relief Not yet recruitingThis multi-center, double-blind study, randomized controlled trial aims to evaluate the efficacy and safety of Temporal Interference transcranial Alternating Current Stimulation (TI-tACS) in patients with major depressive disorder (MDD) and generalized anxiety disorder (GAD). Al…
Phase: NA • Sponsor: Central South University • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Brain training with MRI shows promise for depression
Disease control Recruiting nowPrevious work demonstrated that individuals are able to self-regulate their ventral tegmental area (VTA) activity using real-time biofeedback. The current study expands this approach to a larger sample with repeated training sessions to more robustly characterize the effects of V…
Phase: NA • Sponsor: University of Oxford • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Which biopsy route catches more aggressive prostate cancers?
Diagnosis Recruiting nowThis prospective randomized controlled trial aims to compare transperineal and transrectal cognitive fusion prostate biopsy techniques in patients with suspicious prostate lesions detected by multiparametric magnetic resonance imaging (mpMRI). Patients aged 50-75 years with PI-R…
Phase: NA • Sponsor: Ankara Etlik City Hospital • Aim: Diagnosis
Last updated Jul 19, 2026 00:00 UTC
-
New radiation drug targets tough cancers in early trial
Disease control Not yet recruitingThe purpose of this study is to find out whether 177Lu-DTPA-SC16.56 is a safe treatment for people with small-cell lung cancer or neuroendocrine prostate cancer
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could a year of hormone pills before surgery spare lymph nodes in breast cancer?
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether letrozole, a hormone therapy drug, is effective in treating early-stage, hormone receptor-positive, HER2-negative breast cancer that has spread to nearby lymph nodes in postmenopausal women. The study will also evaluate the safe…
Phase: PHASE2 • Sponsor: Cancer Care Hospital & Research Centre Foundation, Lahore • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New pill aims to keep narcolepsy patients awake and steady
Symptom relief Recruiting nowThe purpose of this study is to measure decreases in daytime sleepiness, cataplexy (sudden loss of muscle tone), and disease symptoms in participants with NT1 when taking ALKS 2680 tablets compared with placebo tablets.
Phase: PHASE3 • Sponsor: Alkermes, Inc. • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
New eczema pill shows promise in Mid-Stage trial
Disease control Not yet recruitingThis double-blind, placebo-controlled study is designed to evaluate the safety and efficacy of ENV-294 in adults with moderate-to-severe atopic dermatitis (AD). The study will compare three dose levels of ENV-294 with placebo administered for 12 weeks. Participants will undergo s…
Phase: PHASE2 • Sponsor: Enveda Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New pill aims to tame severe gut disease
Disease control Not yet recruitingThe purpose of this phase III, multicenter, double-blind, placebo-controlled study is to evaluate the efficacy and safety of Hemay005 compared to placebo as induction and maintenance therapy in Chinese participants with moderately to severely active ulcerative colitis.
Phase: PHASE3 • Sponsor: Ganzhou Hemay Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could short bursts of intense exercise boost heart recovery better than steady workouts?
Disease control Not yet recruitingThis randomized controlled trial aims to compare the effects of High-Intensity Interval Training (HIIT) and Moderate-Intensity Continuous Training (MICT) in patients undergoing Phase II cardiac rehabilitation after coronary artery disease or post-angioplasty. A total of 66 partic…
Phase: NA • Sponsor: Riphah International University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
One scan to catch two silent threats: MRI may spot bone and muscle loss in kidney patients
Diagnosis Not yet recruitingThis is a single-center, observational cohort study aiming to validate the diagnostic value of MRI-FF in identifying osteoporosis and sarcopenia in patients with chronic kidney disease (CKD). A total of 868 participants, including 434 CKD patients and 434 non-CKD controls, will b…
Sponsor: Capital Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
Can a blister beetle extract banish common warts? phase 3 trial investigates
Disease control Not yet recruitingThis is a Phase 3, double-blind, randomized, vehicle-controlled study (Study number VP-CW-302; referred to as COVE-3 \[Cantharidin and Occlusion in Verruca Epithelium\]) to evaluate the efficacy and safety of YCANTH (VP-102/TO-208) treatment in subjects with common warts.
Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Blood test may spot returning cervical cancer before symptoms appear
Knowledge-focused Not yet recruitingPrimary Objective of this study: To investigate the correlation between longitudinal quantitative dynamics of circulating tumor DNA (ctDNA) and HPV-derived cell-free DNA (HPV cfDNA) in peripheral blood and clinical prognosis among patients with recurrent and metastatic cervical c…
Sponsor: Zhejiang Cancer Hospital • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Could a common bile acid pill shield kidneys during cancer surgery?
Disease control Recruiting nowThe goal of this clinical trial is to learn if ursodeoxycholic acid, also called UDCA, can help protect kidney function in adults undergoing partial nephrectomy for kidney tumors. It will also learn about the safety of UDCA when used around the time of surgery. Before the random…
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
AI could spot hidden heart disease without extra needles
Diagnosis Not yet recruitingThe aim of this study is to establish the diagnostic performance of the AngioAI+ System (AngioInsight, Inc, USA) for estimating: 1. Fractional flow reserve (FFR) and 2. Detection of coronary microvascular disease (CMD) SMARTFLOW is a prospective, single-arm, observational multi…
Sponsor: AngioInsight • Aim: Diagnosis
Last updated Jul 15, 2026 00:00 UTC
-
Could same-day activation of cochlear implants speed up hearing recovery?
Disease control Not yet recruitingThis randomized controlled study investigates whether activating a cochlear implant on the day of surgery (same-day activation) leads to faster stabilization of cochlear implant programming compared with the current standard practice of activation approximately 14 days after surg…
Phase: NA • Sponsor: University of Aarhus • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
AI-Powered microscope could diagnose skin cancer in minutes
Diagnosis Not yet recruitingThe goal of this study is to investigate the ability of a machine learning model to evaluate two-photon fluorescence microscopy images of dermatologic biopsies at point of care. The main question it aims to answer is: • How well do two-photon fluorescence images of biopsies tak…
Phase: NA • Sponsor: University of Rochester • Aim: Diagnosis
Last updated Jul 08, 2026 00:00 UTC
-
New drug duo aims to tackle rare leukemia
Disease control ENROLLING_BY_INVITATIONinvestigators propose a phase II, open label-nonrandomized, single arm, multicenter study aiming to assess the safety and efficacy with the combination of Rituximab and Zanubrutinib in patients with HAIRY CELL LUKEMIA HCL, or HAIRY CELL LEUKEMIA VARIANT-HCLv.
Phase: PHASE2 • Sponsor: Bnai Zion Medical Center • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New pill aims to restore skin color in vitiligo patients
Disease control Not yet recruitingThis is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical trial designed to assess the efficacy, safety, and tolerability of LW402 tablets in participants with non-segmental vitiligo. Drawing on the prior/preclinical data of LW402 tablets, this clinic…
Phase: PHASE2 • Sponsor: Shanghai Longwood Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New sleep aid HS-10506 enters final testing phase
Symptom relief Not yet recruitingThe primary purpose of this phase 3 study is to evaluate the safety and the efficacy of HS-10506 (change versus placebo) on latency to persistent sleep (LPS) and wakefulness after sleep onset (WASO) measured by polysomnography (PSG) in Chinese adult participants with insomnia dis…
Phase: PHASE3 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Fetal balloon surgery aims to save babies with rare birth defect
Disease control Recruiting nowThis is a single site, single arm, non-randomized, pilot trial to assess the feasibility and safety of treating severe congenital diaphragmatic hernia (CDH) with Fetal Endoscopic Tracheal Occlusion (FETO) at Columbia University Irving Medical Center (CUIMC)/ NewYork-Presbyterian …
Phase: NA • Sponsor: Vincent Duron • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC